Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.
PET in Multiple Sclerosis.
The secretome of mesenchymal stem cells: Potential implications for neuroregeneration.
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.
A multicomponent T2 relaxometry algorithm for myelin water imaging of the brain.
Effects of dextromethorphan on glial cell function: Proliferation, maturation, and protection from cytotoxic molecules.
An Unusual Case of Bilateral Multifocal Retinal Pigment Epithelial Detachment with Methanol-Induced Optic Neuritis.
Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.
Increasing consistency of disease biomarker prediction across datasets.
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model.
Is it possible to detect active multiple sclerosis plaques using MR thermometry techniques?
The Gender Gap in Multiple Sclerosis: Intersection of Science and Society.
Multiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and Macrophages.
Partnering to Increase Access to Community Exercise Programs for People With Stroke, Acquired Brain Injury and Multiple Sclerosis.
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis.
Reassessment of Lhermitte's sign in multiple sclerosis.
A cytoarchitecture-driven myelin model reveals area-specific signatures in human primary and secondary areas using ultra-high resolution in-vivo brain MRI.
Bone health in patients with multiple sclerosis relapses.
Multicystic demyelinating myelopathy: Widening spectrum of pediatric aquaporin-4 autoimmunity.
[Pay attention to the differences and similarities in the pathogenesis and management of multiple sclerosis and neuromyelitis optica].
Obturator neurolysis using 65% alcohol for adductor muscle spasticity.
Unmasking and provoking severe disease activity in a patient with NMO spectrum disorder.
Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
Cellular immune responses in multiple sclerosis patients treated with interferon-beta.

Pages